This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit March 20, 2014

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click here to view an article on the attempts to solve prescription drug abuse while protecting access for people with pain.

Check out BioDesix VeriStrat test that helps guide second line therapy in non small cell lung cancer (NSCLC).

Click here to view a press release on Medicare coverage.

Click here to view a press release on the study being included in Best of ASCO.

Get up to date information on nutrition and nutrition research from Michael Greger, M.D. at NutritionFacts.org. Click here to view the website!

Granix is now available in the fight against neutropenia during chemotherapy. Click here to view the USPI! Visit www.granixrx.com for more information.

Click here to view the following free CME/CEU program:
Non-Invasive Pre Natal Testing: What Managed Care Needs to Know

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts


Announcing the NAMCP Medical Directors Breast Cancer Resource Center. Click here to visit the website.

The Academy of Oncology Nurse Navigators white paper, "Assessing the Creative Application and Usefulness of NSider: A Tactical Tool for the Oncology Nurse Navigator" was published in the journal, The Oncology Nurse-APN/NP.

Click here to view the white paper.


 




GENOMICS

New gene-scanning approach finds link to heart attack risk 'hiding in plain sight'
Medical News Today
As scanning genomes for disease-related gene variations becomes more commonplace, scientists are pinpointing gene variations that change the way proteins function. Using this approach, a new study found a previously unknown gene variation that appears to make blood lipid levels healthier in humans and reduce risk of heart attacks.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Scientists home in on the real 'fat gene'
Los Angeles Times
If you're a student of fat — and who isn't these days? — you know that the FTO gene is the gene thought to be most responsible for some people's inherited propensity to become obese. Well, forget that. A multinational group of geneticists has discovered that, more likely, the real obesity gene is named IRX3, and it is very far from the FTO gene — or would be, if DNA were to be stretched out in linear fashion instead of coiled up like a skein of yarn.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


2 new genes for bipolar disorder discovered
Medscape
In a genome-wide association study, an international team of researchers has discovered two new risk loci for bipolar disorder and confirmed the presence of three other genes considered to be involved in the illness. The results, from the largest GWAS in bipolar disorder to date, show that 1 of the 2 new regions contains the gene that encodes adenylate cyclase 2, a protein that is involved in signal transmission within nerve cells and is located on chromosome five.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  CEUS: RN, CCM, Safety Training

Get CEUs and Safety Training for your Nurses and Case Managers! Group rates available! CareerSmart offers online CEUs and safety training applicable for Nurses, Case Managers and other healthcare professionals. They are designed to help staff prevent work-related injuries and maintain compliance with mandated continuing education requirements.
 


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Semiconductor based diagnostic technologies could revolutionize personalized medicine
Genetic Engineering & Biotechnology News
The final cost of the Human Genome Project has been estimated at approximately $2.7 billion. At the time, researchers predicted costs would need to fall significantly to enable routine genome sequencing and usher in a new era of personalized and predictive medicine. In late 2001, at a scientific retreat convened by the National Human Genome Research Institute, the threshold cost of $1,000 per genome was conceived.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


101 liver cancer drug candidates pave the way to personalized medicine
Science Codex
The heart disease drug perhexiline is one of 101 compounds predicted to prevent cancer growth in most patients suffering from our most common liver cancer, HCC. This is an outcome from a novel simulation-based approach using personal sets of proteins of six HCC patients. "This is the first time personalized models have been used to find and evaluate new potential drugs," says Professor Jens Nielsen at Chalmers University of Technology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Systemic stem cell therapy reduces malignant mesothelioma growth
medwireNews via News-Medical.net
Systemic delivery of stem cells expressing an apoptosis-inducing protein can successfully incorporate into malignant pleural mesothelioma cells and subsequently induce their death, according to preclinical study findings. While further validation is needed, the research opens up the possibility of using stem cell therapy to decrease tumor burden in this rare and largely untreatable type of lung cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Could stem cells breathe new life into the field of blood substitution?
Scientific American
More than a century after scientists embarked on the quest to find an alternative to the blood coursing through our veins, the dream still will not die. Not after a major study dealt a seemingly fatal blow to the field — determining that the top synthetic blood candidates at the time were all more likely to kill you than to save your life.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


EMERGING MEDICAL TECHNOLOGIES


Wearable technology will see growth in the medical field
USA Today
The top venture capitalists at the digital SXSW conference in Austin, Texas believe wearable technology will see most of its growth in the medical field. While fitness wearables have taken off and thousands have been sold, the medical field is moving in the same direction.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


'Nana Tech': Smart shoes and handheld EKGs could keep seniors safe
LiveScience
Imagine this scenario: It's a cold night in Iowa, or Georgia, or Maine. Your elderly father, who has Alzheimer's disease, is supposed to be in bed. But when you check on him, he's gone. It's a nightmare that anyone who cares for a person with dementia fears: that their loved one will wander and not be found until it's too late.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
New gene-scanning approach finds link to heart attack risk 'hiding in plain sight'
Medical News Today
As scanning genomes for disease-related gene variations becomes more commonplace, scientists are pinpointing gene variations that change the way proteins function.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Are you musical or tone deaf? Genes may be key
HealthDay News
Inheriting certain inner-ear genes may make for top-notch musical chops. A study by Finnish scientists suggests that the genes that influence the structure of auditory pathways — the structures that form the inner ear — may play a significant role in musical ability.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Newly discovered gene may shed light on certain brain disorders
HealthDay News via Heatlh.com
Scientists who discovered a gene that links the thickness of the brain's gray matter to intelligence say their finding might help improve understanding of brain disorders such as autism and schizophrenia.

Share on FacebookTwitterShare on LinkedinE-mail article
read more




MANAGED HEALTHCARE NEWS


Report: Many Americans intend to stay without health insurance
CBS MoneyWatch
A third of Americans without health insurance intend to stay that way, according to a new report. Although the most common reason for doing without coverage is the expense, 70 percent of those planning to stay uninsured did not know about the subsidies afforded under Obamacare that reduce the cost.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Majority of Americans are satisfied with the healthcare system
Business Insider
A new Gallup survey of 1,542 Americans released March 17, says 66 percent of those in the U.S. are satisfied with their current healthcare. The poll asked if the participants had health insurance and asked: "Are you satisfied or dissatisfied with how the healthcare system is working for you?"
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


Zohydro ER: Who are we really here for?
By Jason Poquette
Healthcare is supposed to be about helping sick people, but sometimes I think we have forgotten who we really serve. For example, there has been no shortage of criticism over the FDA decision to approve Zohydro ER back in October. The chief criticisms of this Schedule II extended-release hydrocodone capsule, marketed by Zogenix, are its potency and lack of abuse-deterrent properties. The responses of the media and public health groups like this make me think that we are missing the point. When did our first priority in the development of medications become the manner in which certain persons will intentionally misuse and abuse it?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Drug company will give ailing 7-year-old medicine that could save him
CNN
After days of pleading with drug company executives, Josh Hardy's parents got what they'd been praying for: a chance to get medicine that could help their son survive. The Chimerix pharmaceutical company said that the ailing 7-year-old will receive medicine that doctors hope will help him when he becomes the first patient in a new trial.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    FDA approves treatment for pediatric enzyme disorder (The News Journal)
Study gives hope of altering genes to repel HIV (The New York Times)
Viruses in 700-year-old human feces have antibiotic resistance genes (Medical News Today)
Technology companies eye health market (The Financial Times)
The future of healthcare is social, and techie (USA Today)

Don't be left behind. Click here to see what else you missed.


FAST FACTS
"Seizures can be caused by a number of factors, including epilepsy or fever, and most seizures stop themselves, according to the National Institutes of Health."


 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
March 13, 2014
March 6, 2014
Feb. 27, 2014
Feb. 27, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063